LB30057 (1) is a selective and efficacious oral thrombin inhibitor. Fluorine-substitution on the phenylene ring of the benzamidrazone portion in both compound 1 and its derivatives gave, in many cases, enhanced oral absorption in rats while maintaining the intrinsic potency and selectivity. Compound 2 demonstrated a 3-fold increase in absorption.
[Pearson, Daniel A.; Lister-James, John; McBride, William J.; Wilson, David M.; Martel, Lawrence J.; Civitello, Edgar R.; Dean, Richard T. Journal of Medicinal Chemistry, 1996 , vol. 39, # 7 p. 1372 - 1382]
[Kim, Sangsoo; Hwang, Sang Yeul; Kim, Young Kwan; Yun, Mikyung; Oh, Yeong Soo Bioorganic and Medicinal Chemistry Letters, 1997 , vol. 7, # 7 p. 769 - 774]